Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40RA3 | ISIN: US56270V2051 | Ticker-Symbol:
NASDAQ
21.11.24
15:30 Uhr
2,420 US-Dollar
-0,050
-2,02 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MANGOCEUTICALS INC Chart 1 Jahr
5-Tage-Chart
MANGOCEUTICALS INC 5-Tage-Chart

Aktuelle News zur MANGOCEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.11.MANGOCEUTICALS, INC. - 8-K, Current Report-
01.11.MGRX stock touches 52-week low at $2.1 amid market challenges1
31.10.MANGOCEUTICALS, INC. - 8-K, Current Report1
25.10.Mangoceuticals issues shares, raises $78,787 in capital1
22.10.MangoRx hits back at Eli Lilly's weight loss drug copycat claims6
22.10.Mangoceuticals Opts For Strategic Alternatives1
22.10.Mangoceuticals explores strategic alternatives to boost shareholder value2
MANGOCEUTICALS Aktie jetzt für 0€ handeln
22.10.Mangoceuticals To Defend Against Eli Lilly's Lawsuit Over Alleged Copying Of Weight-Loss Drugs381INDIANAPOLIS (dpa-AFX) - Mangoceuticals Inc. (MGRX) announced that Eli Lilly has made public allegations and filed a lawsuit against the company, claiming that MangoRx improperly copied its...
► Artikel lesen
22.10.Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit6
21.10.MangoRx faces lawsuit from Eli Lilly over medication5
21.10.Mangoceuticals, Inc.: MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly182Dallas, Texas, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness...
► Artikel lesen
21.10.MANGOCEUTICALS, INC. - 8-K, Current Report3
18.10.Centurion One Capital Corp.: Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024254Dallas, Texas--(Newsfile Corp. - October 18, 2024) - Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling men's health and wellness products via a secure telemedicine...
► Artikel lesen
11.10.Mangoceuticals announces 1-for-15 reverse stock split3
11.10.Mangoceuticals, Inc. Announces 1-for 15 Reverse Stock Split As Part Of Nasdaq Compliance Plan74DALLAS, TX, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and...
► Artikel lesen
11.10.MANGOCEUTICALS, INC. - 8-K, Current Report1
03.10.Mangoceuticals, Inc.: MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions168Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness...
► Artikel lesen
03.10.Mangoceuticals issues equity for consulting and marketing services2
01.10.MangoRx launches oral weight loss treatment Slim-
01.10.MangoRx führt orale Behandlung zur Gewichtsreduktion ein: Slim1
Seite:  Weiter >>
55 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1